An underground economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Popularity Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to contact these accounts privately for source information, while also receiving promotional offers.
Active Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with thousands of participants share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the next Ozempic.
Medical Experts Express Concerns
However, physicians and chemists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is worrisome and could lead to users injecting products of unknown origin.
Some experts said the demand for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Several content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still breach medicines, advertising, and customer regulations, risking fines, legal action or imprisonment.
Platform Response and Material Elimination
Based on the social media company, the platform has taken down problematic content and prohibited associated hashtags and search suggestions. The organization stated it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.
Digital Trading Operations
Research also discovered communities with up to nine thousand members marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, glowing reviews and detailed instructions for preparing or injecting at home.
After minutes of entering one group, a seller posted contact information, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about weight, health issues or previous experience.
Product Information and Costs
Inside these groups, posts show dark colored parcels with postal service stickers, stating to contain new batches. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When questioned how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service said it actively monitored harmful material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they cannot confirm. Even if the science behind this drug is sound, these digital versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.
Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose patients to potentially significant medical dangers”.
